Cargando…
HIV-Helicobacter pylori Co-Infection: Antibiotic Resistance, Prevalence, and Risk Factors
BACKGROUND: Patients infected with human immunodeficiency virus (HIV) are living longer due to the availability of more potent treatments. However, prescription of antibiotics to treat or prevent infections in these patients may increase the likelihood of co-infection with antibiotic-resistant speci...
Autores principales: | Nkuize, Marcel, De Wit, Stéphane, Muls, Vinciane, Delforge, Marc, Miendje Deyi, Véronique Y., Cadière, Guy B., Buset, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686959/ https://www.ncbi.nlm.nih.gov/pubmed/26691198 http://dx.doi.org/10.1371/journal.pone.0145119 |
Ejemplares similares
-
Primary antibiotic resistance of Helicobacter pylori isolates is twofold more frequent in HIV‐positive than HIV‐negative individuals: A descriptive observational study
por: Nkuize, Marcel, et al.
Publicado: (2021) -
Helicobacter pylori Infections in Children
por: Nguyen, Julie, et al.
Publicado: (2023) -
Issues Related to the Treatment of H. pylori Infection in People Living with HIV and Receiving Antiretrovirals
por: Nkuize, Marcel, et al.
Publicado: (2022) -
Helicobacter pylori and Human Immunodeficiency Virus Co-Infection: Potential Implications for Future Gastric Cancer Risk
por: Nkuize, Marcel, et al.
Publicado: (2023) -
Combination ledipasvir-sofosbuvir for the treatment of chronic hepatitis C virus infection: a review and clinical perspective
por: Nkuize, Marcel, et al.
Publicado: (2016)